DNA Damage Is a Potential Marker for TP53 Mutation in Colorectal Carcinogenesis

被引:0
作者
Scalise J.R. [1 ]
Poças R.C.G. [1 ]
Caneloi T.P. [2 ]
Lopes C.O. [2 ]
Kanno D.T. [2 ]
Marques M.G. [2 ]
Valdivia J.C.M. [2 ]
Maximo F.R. [2 ]
Pereira J.A. [3 ]
Ribeiro M.L. [1 ]
Priolli D.G. [1 ,4 ]
机构
[1] Postgraduate Programme Strictu Senso in Health Science, Sao Francisco University Medical School, Sao Paulo
[2] Scientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo
[3] Department of Pathology, Sao Francisco University Medical School, Sao Paulo
[4] Rua São Vicente 614. Jardim Paulista, Atibaia, CEP: 12947-390, SP
基金
巴西圣保罗研究基金会;
关键词
Adenocarcinoma; Adenoma; DNA damage; Immunohistochemistry; Tumor suppressor protein p53;
D O I
10.1007/s12029-016-9846-0
中图分类号
学科分类号
摘要
Purpose: The ability to measure oxidative DNA damage in a tissue allows establishment of the relationship between DNA damage and mutations in normal and neoplastic cells. It is well known that TP53 is a key inhibitor of tumor development and preserves the genome integrity in each cell. The aim of the present study was to investigate the relationship between DNA damage and TP53 mutation in colorectal adenoma and adenocarcinoma, and the value of DNA damage as potential marker of TP53 mutation in non-tumor tissues adjacent to colon malignant lesions. Methods: Tissue samples were obtained by colonoscopy from patients with adenoma and/or adenocarcinoma and from healthy volunteers. Diagnosis was defined by histopathology. Immunohistochemistry with computer-assisted image analysis was performed to quantify TP53 mutation. Oxidative DNA damage was determined by comet assay. Statistical analyses were performed with 5 % of significance level. Results: The TP53 level was higher in non-tumor tissues from tumor patients than in normal tissues from healthy volunteers (p = 0.01). Likewise, higher TP53 levels were observed in tumor tissues compared with the non-tumor tissues (p = 0.00). Oxidative DNA damage levels were higher in tumor tissues than in non-tumor tissues (p = 0.00). The amount of TP53 (p = 0.00) and oxidative DNA damage (p = 0.00) in normal and tumor tissue was related. The relationship between oxidative DNA damage and TP53 mutation was demonstrated in all samples (p = 0.00). Conclusion: Oxidative DNA damage is an intervening variable for TP53 mutation in colorectal adenoma-carcinoma. Our data suggests that oxidative DNA damage is a potential marker of TP53 mutation in colorectal carcinogenesis. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:409 / 416
页数:7
相关论文
共 50 条
  • [1] Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
    Kim, Ji-Yeon
    Park, Kyunghee
    Jung, Hae Hyun
    Lee, Eunjin
    Cho, Eun Yoon
    Lee, Kwang Hee
    Bae, Soo Youn
    Lee, Se Kyung
    Kim, Seok Won
    Lee, Jeong Eon
    Nam, Seok Jin
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1338 - 1350
  • [2] Adenocarcinoma arising in branchioma with a KRAS and TP53 mutation
    Taniguchi, Natsuki
    Satou, Akira
    Ito, Takanori
    Nakaguro, Masato
    Tsuzuki, Toyonori
    PATHOLOGY INTERNATIONAL, 2023, 73 (07) : 317 - 322
  • [3] Number of rare germline CNVs and TP53 mutation types
    Silva, Amanda G.
    Achatz, Maria Isabel W.
    Krepischi, Ana C. V.
    Pearson, Peter L.
    Rosenberg, Carla
    ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
  • [4] The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer
    Osakabe, Mitsumasa
    Yamada, Noriyuki
    Sugimoto, Ryo
    Uesugi, Noriyuki
    Nakao, Eiichi
    Honda, Michitaka
    Yanagawa, Naoki
    Sugai, Tamotsu
    VIRCHOWS ARCHIV, 2024, 486 (2) : 333 - 341
  • [5] Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation
    Macedo, Gabriel S.
    da Motta, Leonardo Lisboa
    Giacomazzi, Juliana
    Netto, Cristina B. O.
    Manfredini, Vanusa
    Vanzin, Camila S.
    Vargas, Carmen Regla
    Hainaut, Pierre
    Klamt, Fabio
    Ashton-Prolla, Patricia
    PLOS ONE, 2012, 7 (10):
  • [6] Advances in carcinogenesis: A historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis
    Soussi, Thierry
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1816 (02): : 199 - 208
  • [7] TP53 Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors
    Verdijk, Robert M.
    den Bakker, Michael A.
    Dubbink, Hendrikus J.
    Hop, Wim C. J.
    Dinjens, Winand N. M.
    Kros, Johan M.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (01) : 16 - 26
  • [8] Recurrent fallopian tube carcinoma:: TP53 mutation and clinical course
    Hellström, AC
    Blegen, H
    Malec, M
    Silfverswärd, C
    Lystad, S
    Borresen-Dale, A
    Auer, G
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2000, 19 (02) : 145 - 151
  • [9] TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors
    Sakai, Eiji
    Fukuyo, Masaki
    Matsusaka, Keisuke
    Ohata, Ken
    Doi, Noriteru
    Takane, Kiyoko
    Matsuhashi, Nobuyuki
    Fukushima, Junichi
    Nakajima, Atsushi
    Kaneda, Atsushi
    CANCER SCIENCE, 2016, 107 (06) : 820 - 827
  • [10] p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
    You-Na Sung
    Deokhoon Kim
    Jihun Kim
    Diagnostic Pathology, 17